HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Hancock Selected Research

PMitCEBO protocol

3/2006A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
5/2001Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Hancock Research Topics

Disease

4Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2006 - 05/2001
3Neoplasms (Cancer)
05/2014 - 08/2000
3Lymphoma (Lymphomas)
12/2009 - 08/2004
2Kidney Neoplasms (Kidney Cancer)
01/2008 - 10/2003
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2004 - 04/2000
1Renal Cell Carcinoma (Grawitz Tumor)
01/2008
1Cardiotoxicity
08/2005
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2005
1Ovarian Neoplasms (Ovarian Cancer)
08/2004
1Ovarian Epithelial Carcinoma
08/2004
1Polyps
08/2001
1Intestinal Polyps
08/2001
1Adenoma (Adenomas)
08/2001
1Colorectal Neoplasms (Colorectal Cancer)
08/2001
1Melanoma (Melanoma, Malignant)
05/2001
1Trophoblastic Neoplasms (Trophoblastic Tumor)
08/2000

Drug/Important Bio-Agent (IBA)

3Doxorubicin (Adriamycin)FDA LinkGeneric
08/2005 - 05/2001
2InterferonsIBA
08/2004 - 05/2001
2Interferon-alpha (Interferon Alfa)IBA
08/2004 - 05/2001
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
05/2014
1Cisplatin (Platino)FDA LinkGeneric
12/2009
1CalciumIBA
12/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2009
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1MagnesiumIBA
12/2009
1MethylprednisoloneFDA LinkGeneric
12/2009
1PotassiumIBA
12/2009
1SRL172IBA
01/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2005
1Prednisolone (Predate)FDA LinkGeneric
08/2005
1Vincristine (Oncovin)FDA LinkGeneric
08/2005
1Daunorubicin (Cerubidine)FDA LinkGeneric
08/2005
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
08/2005
1fludarabineIBA
08/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2004
1Flavin-Adenine Dinucleotide (FAD)IBA
08/2004
1Protein Kinase CIBA
10/2003
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2001
1Cyclooxygenase 1IBA
08/2001
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2001
1Sulindac (Copal)FDA LinkGeneric
08/2001
13- (3,4- difluorophenyl)- 4- (4- (methylsulfonyl)phenyl)- 2(5H)- furanoneIBA
08/2001
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2001
1Leucovorin (Folinic Acid)FDA Link
08/2000
1Methotrexate (Mexate)FDA LinkGeneric
08/2000
1Rituximab (Mabthera)FDA Link
04/2000
1Monoclonal AntibodiesIBA
04/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
12/2009 - 08/2000
4Therapeutics
05/2014 - 08/2000
2PMitCEBO protocol
03/2006 - 05/2001
1Nephrectomy
01/2008
1Radiotherapy
03/2004
1Combination Drug Therapy (Combination Chemotherapy)
05/2001
1Salvage Therapy
08/2000